Systematic Elucidation of the Potential Mechanism of Erzhi Pill against Drug-Induced Liver Injury via Network Pharmacology Approach

Table 1

A list of the final selected compounds from EZP for network analysis.

No.	Molecule name	Structure	OB (%)	DL	Herb
1	Luteolin		36.16	0.25	LLF, EH
2	Quercetin		46.43	0.28	LLF, EH
3	Beta-sitosterol		36.91	0.75	LLF
4	Kaempferol		41.88	0.24	LLF
5	Acacetin		34.97	0.24	EH
6	Linarin		39.84	0.71	EH
7	Butin		69.94	0.21	EH
8	3′-O-Methylorobol		57.41	0.27	EH
9	Pratensein		39.06	0.28	EH
10	Demethylwedelolactone		72.13	0.43	EH
11	Wedelolactone		49.60	0.48	EH
12	Taxifolin		57.84	0.27	LLF
13	Lucidumoside D		48.87	0.71	LLF
14	Lucidumoside D_qt		54.41	0.47	LLF
15	(20S)-24-ene-3β, 20-diol-3-acetate		40.23	0.82	LLF
16	Eriodictyol		71.79	0.24	LLF
17	Syringaresinol diglucoside_qt		83.12	0.80	LLF
18	Lucidusculine		30.11	0.75	LLF
19	Olitoriside		65.45	0.23	LLF
20	Olitoriside_qt		103.23	0.78	LLF
21	Oleanolic acid		29.02	0.76	LLF
22	Salidroside		7.01	0.20	LLF
23	Specnuezhenide		19.30	0.50	LLF